Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy...

February 21, 2024

AstraZeneca’s Tagrisso plus chemotherapy appoved for lung cancer in the US

AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit...

February 19, 2024

GSK completes acquisition of Aiolos Bio, expanding respiratory biologics portfolio

GSK plc has completed the acquisition of Aiolos Bio, expanding its respiratory biologics portfolio with AIO-001, a potential treatment for asthma patients with low T2 inflammation. The acquisition includes an upfront payment of $1 billion and milestone payments...

February 15, 2024

GSK receives FDA fast track designation for Bepirovirsen for Chronic Hepatitis B

GSK plc has received Fast Track designation from the FDA for bepirovirsen, an investigational drug for chronic hepatitis B treatment. This designation highlights the need for effective medications to address this serious condition...

February 12, 2024

AstraZeneca reports Strong Growth and Pipeline Momentum in FY and Q4 2023

AstraZeneca reports strong FY and Q4 2023 results, with revenue growth, new medicine approvals, and optimistic growth projections for 2024...

February 8, 2024

GSK plc -5.0% potential downside indicated by Barclays

February 7, 2024

GSK’s RSV vaccine for adults 50-59 at increased risk accepted by FDA for Priority Review

GSK plc's application to extend its RSV vaccine indication to adults aged 50-59 at risk has been accepted by the FDA for priority review. If approved, it would be the first vaccine for this population. The application is supported by positive phase III trial results...

February 6, 2024

GSK reaches confidential settlement with David Browne in Zantac case

GSK has reached a confidential settlement with David Browne, resolving a California state court case. The company will continue to defend itself in other Zantac cases...

February 1, 2024

GSK plc 2.6% potential upside indicated by Barclays

January 31, 2024

GSK plc delivers Strong Sales and Earnings Growth in 2023

GSK plc announces strong financial results, with sales and profits driven by broad-based performance and COVID-19 vaccine sales...

January 31, 2024

Haleon to sell ChapStick brand to Suave Brands Company

Haleon plc has entered into a binding agreement to sell the ChapStick brand to Suave Brands Company, generating $430 million in cash proceeds...

January 25, 2024

GSK plc .9% potential upside indicated by Barclays

January 19, 2024

GSK plc .9% potential upside indicated by Barclays

January 12, 2024

GSK’s Nucala approved in China for use in severe asthma

January 10, 2024

GSK expands respiratory pipeline with Aiolos Bio acquisition

January 9, 2024

AstraZeneca plc 21.2% potential upside indicated by Jefferies

December 29, 2023

GSK plc 8.2% potential upside indicated by Barclays

December 29, 2023

AstraZeneca’s Wainua receives FDA approval in the US

December 22, 2023

GSK plc 12.9% potential upside indicated by Berenberg Bank

December 12, 2023

News and Interview Alerts

Company Presentations

Falanx Assynt – A Company Overview

Immotion Group the exciting world of VR Location and Home Based Entertainment (Interview)

Symphony Environmental Technologies 2020 Results Presentation

Anexo Group Final Results Investor Presentation 2021

Q&As

Apax Global Alpha: Stronger prospects for 2025 and beyond (LON:APAX)

1 May 2025

Hardman & Co

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

ICG Enterprise Trust Investor Seminar 2025: Resilience and Growth

2 July 2025

Volta Finance: Volatility put into context

25 June 2025

ICG Enterprise Trust: Investing in resilience, delivering growth

22 May 2025

Green News

Ilika plc Stereax Micro Batteries Enter Production with Customer Deliveries on the Horizon (Video)

18 August 2025

Drax Group appoints former Shell Executive Frank Lemmink as CFO

1 July 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

One Health Group Plc AIM Listing Powers Expansion with £7.8M Surgical Hub Strategy (Video)

Boku Inc. Surging Growth, 2025 Outlook, and the Future of Local Payment Methods (Video)

accesso Technology Group Strong Recovery, Sharpened Strategy, and a Discount Valuation That Stands Out

Ilika plc 50Ah Goliath Battery Milestone Marks a 25-Fold Leap in EV Tech (Video)

TEAM plc Profits in Sight as Revenues Soar and Growth Accelerates (Video)

Avation PLC Soaring Lease Rates, Strong Results, and a Smart Fleet Strategy (Video)

BrokerTalk

Pharos Energy Eyes Future Growth and 5.6% Dividend Yield – Shore Capital

27 March 2025

Arbuthnot Banking Group Delivers Solid Results with Resilient Growth – Shore Capital

27 March 2025

Quadrise Charts a Confident Course Towards Clean Marine Fuel – Shore Capital

27 March 2025

Valeura Energy’s Strong Position Reinforced as Auctus Reiterates C$13 Target – Auctus Advisors LLP

25 March 2025

Pulsar Helium’s Project Finance Boost Marks Key Milestone – Auctus Advisors

24 March 2025

Funds

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Tesco PLC (TSCO.L): Navigating Steady Growth in a Competitive Market

25 August 2025

WPP PLC ORD 10P (WPP.L): Navigating Market Challenges with Strategic Creativity

25 August 2025

Vistry Group PLC (VTY.L): Navigating the Peaks and Valleys of the UK Housing Market

25 August 2025

Vodafone Group PLC (VOD.L): Navigating Challenges with Strategic Moves and Dividend Appeal

25 August 2025

Taylor Wimpey PLC (TW.L): Examining the Valuation Puzzle and Dividend Appeal

25 August 2025

Health

GSK plc 10.1% potential upside indicated by Berenberg Bank

February 22, 2024

ViiV Healthcare announces Superiority of long-acting HIV Therapy over daily oral treatment

ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy...

February 21, 2024

AstraZeneca’s Tagrisso plus chemotherapy appoved for lung cancer in the US

AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit...

February 19, 2024

GSK completes acquisition of Aiolos Bio, expanding respiratory biologics portfolio

February 15, 2024

GSK receives FDA fast track designation for Bepirovirsen for Chronic Hepatitis B

February 12, 2024

AstraZeneca reports Strong Growth and Pipeline Momentum in FY and Q4 2023

AstraZeneca reports strong FY and Q4 2023 results, with revenue growth, new medicine approvals, and optimistic growth projections for 2024...

February 8, 2024

GSK plc -5.0% potential downside indicated by Barclays

February 7, 2024

GSK’s RSV vaccine for adults 50-59 at increased risk accepted by FDA for Priority Review

February 6, 2024

GSK reaches confidential settlement with David Browne in Zantac case

GSK has reached a confidential settlement with David Browne, resolving a California state court case. The company will continue to defend itself in other Zantac cases...